Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 9Recruiting 5Terminated 2Enrolling by invitation 2Active not recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 723Neoplasms 461Prostatic Neoplasms 398Carcinoma, Non-Small-Cell Lung 387Lung Neoplasms 310Leukemia, Myeloid, Acute 301Multiple Myeloma 270Colorectal Neoplasms 243Neoplasm Metastasis 240Pancreatic Neoplasms 238Leukemia 235Melanoma 217Lymphoma 213Precursor Cell Lymphoblastic Leukemia-Lymphoma 204Brain Neoplasms 195Recurrence 178Head and Neck Neoplasms 177Lymphoma, Non-Hodgkin 174Leukemia, Lymphocytic, Chronic, B-Cell 168Myelodysplastic Syndromes 167Ovarian Neoplasms 160Carcinoma, Hepatocellular 154Glioblastoma 149Carcinoma, Renal Cell 137Rectal Neoplasms 134Colonic Neoplasms 129Lymphoma, Large B-Cell, Diffuse 125Lymphoma, Follicular 125Hodgkin Disease 116Squamous Cell Carcinoma of Head and Neck 109

Interventions

antineoplaston AS 2-1 1antineoplaston A10 1Talaporfin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × Neurofibroma × Clear all
NCT02988726 2017-07-26

Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma

Burzynski Research Institute

Phase 2 Terminated
3 enrolled
CNS

Neurilemmoma, Neurofibroma, Central Nervous System Neoplasms

NCT00716469 2015-04-15

PDT

Children's Hospital of Philadelphia

Phase 1 Terminated
7 enrolled
CNS

Neurofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡